Table 2.
Correlation Matrix of EPVS, WMHs, Lacunes, and Cerebral MBs With Neuroimaging and Blood-Based Biomarkers
| Variable | EPVS (Staals) | WMH (Staals) | Lacunes (Staals) | MB (Staals) |
| MRI markers | ||||
| GM/TIV | −0.100** (−0.156 to −0.031) | −0.288** (−0.344 to −0.233) | −0.192** (−0.249 to −0.126) | −0.174** (−0.229 to −0.107) |
| WM/TIV | −0.161** (−0.220 to −0.096) | −0.188** (−0.252 to −0.124) | −0.117** (−0.174 to −0.046) | −0.144** (−0.201 to −0.075) |
| Total GM perfusion (mL/min/100 g) | −0.040 (−0.104 to 0.024) | −0.116** (−0.175 to −0.044) | −0.140** (−0.207 to −0.065) | 0.003 (−0.074 to 0.069) |
| BBM | ||||
| Aβ42 (pg/mL) | −0.008 (−0.071 to 0.057) | 0.072* (0.015 to 0.142) | −0.007 (−0.071 to 0.057) | 0.027 (−0.028 to 0.090) |
| Aβ40 (pg/mL) | 0.056 (−0.011 to 0.120) | 0.165** (0.100 to 0.229) | 0.067* (−0.002 to 0.130) | 0.097** (0.032 to 0.160) |
| Aβ42/Aβ40 (ratio) | −0.077* (−0.144 to −0.006) | −0.084* (−0.149 to −0.017) | −0.086* (−0.147 to −0.023) | −0.069* (−0.135 to −0.002) |
| OAβ (ratio) | 0.012 (−0.077 to 0.092) | 0.062 (−0.026 to 0.151) | 0.022 (−0.071 to 0.111) | 0.034 (−0.059 to 0.134) |
| NfL (pg/mL) | 0.169** (0.112 to 0.242) | 0.329** (0.267 to 0.390) | 0.166** (0.109 to 0.227) | 0.134** (0.074 to 0.190) |
| GFAP (pg/mL) | 0.166** (0.104 to 0.228) | 0.266** (0.201 to 0.328) | 0.073* (0.007 to 0.140) | 0.109** (0.049 to 0.172) |
| p-tau181 (pg/mL) | 0.087** (0.022 to 0.152) | 0.193** (0.132 to 0.256) | 0.142** (0.080 to 0.205) | 0.095** (0.025 to 0.161) |
Abbreviations: Aβ = β-amyloid; BBM = blood biomarkers; GFAP = glial fibrillary acidic protein; GM = grey matter; MB = microbleeds; NfL = neurofilament light chain; OAβ = amyloid β oligomers; EPVS = enlarged perivascular spaces; p-tau181 = phosphorylated tau 181; TIV = total intracranial volume; WM = white matter; WMH = white matter hyperintensities.
Correlation coefficients (95% CI), *p < 0.05, **p < 0.005. OAβ, NfL, GFAP, and pTau181 log transformed.